Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
Clinical trial NCT06531941 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06531941
- Sponsor
- MBX Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2027-05-27
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.